OLIG2 as a specific marker of oligodendroglial tumour cells

Lancet

Volumn 358, Issue 9278, 2001, Pages 298-300

  Marie, Yannick ^a   Sanson, Marc ^a,b   Mokhtari, Karima ^b   Leuraud, Pascal ^a   Kujas, Michèle ^b   Delattre, Jean Yves ^a,b   Poirier, Jacques ^b   Zalc, Bernard ^a   Hoang Xuan, Khê ^a,b,c  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c Fédération Neurologique Mazarin   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TUMOR MARKER;

ARTICLE; ASTROCYTOMA; BRAIN METASTASIS; BRAIN TUMOR; CANCER STAGING; CELL LABELING; CLINICAL ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTRACTABLE EPILEPSY; MENINGIOMA; MOUSE; NEUROEPITHELIOMA; NONHUMAN; NUDE MOUSE; OLIGODENDROGLIA; OLIGODENDROGLIOMA; PRIORITY JOURNAL; STEM CELL; TUMOR CELL;

EID: 0035963934     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(01)05499-X     Document Type: Article

References (5)

1. Improving diagnostic accuracy and interobserver concordancein the classification and grading of primary gliomas
2. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system
3. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors
4. Molecular genetic analysis of oligodendroglial tumors shows preferential allelic deletions on 19q and 1p
5. Oligodendroglioma: An appraisal of recent data pertaining to diagnosis and treatment